Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 56Breast Neoplasms 50Ovarian Neoplasms 33Triple Negative Breast Neoplasms 27Endometrial Neoplasms 25Lung Neoplasms 24Neoplasm Metastasis 23Fallopian Tube Neoplasms 23Squamous Cell Carcinoma of Head and Neck 19Parkinson Disease 4, Autosomal Dominant Lewy Body 18Neoplasms 14Esophageal Squamous Cell Carcinoma 12Esophageal Neoplasms 12Carcinoma, Ovarian Epithelial 9Stomach Neoplasms 8Head and Neck Neoplasms 8Colorectal Neoplasms 8Carcinoma 8Adenocarcinoma Of Esophagus 7Adenocarcinoma 7Peritoneal Neoplasms 6Uterine Cervical Neoplasms 5Melanoma 5Small Cell Lung Carcinoma 4Oropharyngeal Neoplasms 4Cholangiocarcinoma 4Carcinoma, Transitional Cell 4Uterine Neoplasms 3Recurrence 3Pancreatic Neoplasms 3

Interventions

Specimen Handling 3Taxes 2Carboplatin 2pembrolizumab 1pegfilgrastim 1olaparib 1X-Rays 1Therapeutics 1Radiotherapy 1Radiation 1Panitumumab 1Palliative Care 1Paclitaxel 1Methods 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interviews as Topic 1Indocyanine Green 1Exercise Test 1Epirubicin 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Clostridium perfringens epsilon-toxin 1Albumin-Bound Paclitaxel 1Accelerometry 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Paclitaxel × 90 days × Clear all
NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
42 enrolled
Breast

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡